aprotinin

enUK

aprotinin

[ap″ro-ti´nin] an inhibitor of proteolytic enzymes, used as an antihemorrhagic to reduce perioperative blood loss in patients undergoing bypass" >cardiopulmonary bypass during bypass graft" >coronary artery bypass graft; administered intravenously.

aprotinin

(ā-prōt′n-ĭn, ă-prōt′-)n. A polypeptide obtained from bovine lungs that is a protease inhibitor and has been used to reduce bleeding in patients undergoing cardiopulmonary bypass surgery. It was largely withdrawn from the market in 2007 because of safety concerns.

aprotinin

A bovine polypeptide and protease inhibitor with antifibrinolytic activity that derives from basic pancreatic trypsin inhibitor (BPTI), which was added to fibrinogen in “fibrin glue”, theoretically enhancing the persistence of the fibrin clot.
It was pulled from the international market in 2007, given the concern that aprotinin increased the risk of complications and death during surgery. In 2012 the European Medicines Agency concluded that the benefits outweighed the risks, and recommended the suspension be lifted.

aprotinin

A drug used in the treatment of bleeding resulting from the excessive breakdown of the fibrin that forms blood clots. An antifibrinolytic. A brand name is Trasylol. In September 2006 the FDA issued a warning that this drug could cause renal failure, congestive heart failure, stroke and death.

单词	aprotinin
释义	aprotinin enUK a·pro·ti·nin A0386750 (ā-prōt′n-ĭn, ă-prōt′-)n. A polypeptide obtained from bovine lungs that is a protease inhibitor and has been used to reduce bleeding in patients undergoing cardiopulmonary bypass surgery. It was largely withdrawn from the market in 2007 because of safety concerns. [a- + prot(e)in(ase) + -in.] aprotinin enUK aprotinin [ap″ro-ti´nin] an inhibitor of proteolytic enzymes, used as an antihemorrhagic to reduce perioperative blood loss in patients undergoing bypass" >cardiopulmonary bypass during bypass graft" >coronary artery bypass graft; administered intravenously. aprotinin (ā-prōt′n-ĭn, ă-prōt′-)n. A polypeptide obtained from bovine lungs that is a protease inhibitor and has been used to reduce bleeding in patients undergoing cardiopulmonary bypass surgery. It was largely withdrawn from the market in 2007 because of safety concerns. aprotinin A bovine polypeptide and protease inhibitor with antifibrinolytic activity that derives from basic pancreatic trypsin inhibitor (BPTI), which was added to fibrinogen in “fibrin glue”, theoretically enhancing the persistence of the fibrin clot. It was pulled from the international market in 2007, given the concern that aprotinin increased the risk of complications and death during surgery. In 2012 the European Medicines Agency concluded that the benefits outweighed the risks, and recommended the suspension be lifted. aprotinin A drug used in the treatment of bleeding resulting from the excessive breakdown of the fibrin that forms blood clots. An antifibrinolytic. A brand name is Trasylol. In September 2006 the FDA issued a warning that this drug could cause renal failure, congestive heart failure, stroke and death.
随便看	vector model of atomic structure vector-modulator-based phase-shifter vector momentum vector multiple access channel vector multiplication vector network analysis vector normalization vector parabolic wave equation vector partial product generator vector permute unit vector point function vector potential vector potential analysis vector potential dyadic green's function vector power vector processing vector processor vector processors vector product vector product exchange vector product format vector product format production system vector products vector product standard vector program

aprotinin

a·pro·ti·nin

aprotinin

aprotinin

aprotinin

aprotinin

aprotinin